Download Slides page 3

Download Slides

Name

Presentation

Session

Download Slide

Yauheniya Varabyova
University of Hamburg, Hamburg Center for Health Economics

International comparisons of the technical efficiency of the hospital sector: Panel data analysis of OECD countries using parametric and non-parametric approaches

Hospital Efficiency I

ds

Alastair Dickson National Health Service

Treatment of newly diagnosed depression in primary care: Does the current system of GP payment improve clinical outcomes?

Economics of Depression

Bander Balkhi Massachusetts College of Pharmacy and Health Sciences

Generic Competition in the United States and New Zealand Pharmaceutical Markets: A Comparative Analysis

Generic Drug Competition

Emily Callander University of Sydney

A new multidimensional measure of poverty for Australia: the freedom poverty measure

Health Status Assessment Tools

Gisela Hostenkamp University of Southern Denmark

 

Tendering, market structure and generic competition: An empirical investigation from the Danish market for hospital pharmaceuticals

Generic Drug Competition

Gunnar Rosenqvist Hanken School of Economics & National Institute for Health and Welfare

Demand for tobacco products in Finland over the last five decades: Have price and other control policies mattered?

Tobacco Demand

Jeff Richardson Monash University

Incorporating social perspectives into economic evaluation: Social Cost Utility Analysis

Health Status Assessment Tools

Kim Longfield Population Services International

Putting health metrics into practice: using the disability-adjusted life year for strategic decision making

The Research to Policy Link

Michio Yuda
Chukyo University

An Empirical Analysis of the relationship between medical spending and long-term care spending in the last year of life

Care at the End-of-Life

Sakthivel Selvaraj Public Health Foundation of India

Price Elasticity of Tobacco Products among Quintile Groups in India, 2009-10

Tobacco Demand

Sandra Rodriguez Universidad del Norte

Effects of the health insurance market structure on insurance coverage in Colombia

Impact of Insurance

Tiara Marthias
Gadjah Mada University, Faculty of Medicine

Maternal Health Care Utilization in Indonesia: Regional Economic Status and the Inequities

Role of Universal Coverage in Maternal Care

Agne Suziedelyte University of New South Wales

Hips and hearts: the variation in moral hazard across hospital procedures

Hospital Treatment

Bastian Ravesteijn Erasmus University Rotterdam & Tinbergen Institute

The wear and tear of health: what is the role of occupation?

Impact of Employment on Health

Elaine Baruwa
Abt Associates, Inc.

An economic assessment of decentralizing anti-retroviral services from hospitals to primary health care centers in Nigeria: A matched difference-in-difference analysis

Dealing With HIV

Renate Strobl University of Basel

Community-based health insurance in Rwanda: An effective measure against child labour?

Bringing Health Insurance to the Uninsured

Rupendra Shrestha University of Sydney

The economic impacts of retiring early due to illness: impacts on individuals and on government

Economics and Aging

Shivaani Prakash Brown University

The Association between Mental Disorders and Lost Earnings in Chile: A Cost of Illness Analysis from the Chile Psychiatric Prevalence Study

Cost of Mental Health Care

Shivaani Prakash Brown University

The Association between Mental Disorders and Lost Earnings in Chile: A Cost of Illness Analysis from the Chile Psychiatric Prevalence Study

Cost of Mental Health Care

Tanvir Ahmed International Center for Diarrhoeal Disease Research-Bangladesh (ICDDR,B)

Challenges of Community Based Health Insurance Implementation: Experience from Amader Shasthya, Chakaria

Bringing Health Insurance to the Uninsured

 

    

Download Slides page 2

Download Slides

Name

Presentation

Session

Download Slide

Joe Hirschberg University of Melbourne

Inverse test confidence intervals for the critical values in dose response and willingness to pay analysis

Economic Evaluation Methods

ds

Judith Kabajulizi London School of Hygiene & Tropical Medicine

Macroeconomic Implications of Health Sector Reforms in Uganda: A Computable General Equilibrium Analysis

Economic Evaluation of Systems

Justyna Hartmann Hannover Medical School

Differences within high-cost patients: how do high-cost patients of different sexes and ages differ in their usage of health service sectors and their distribution of diagnoses?

Utilization of Health Care

Laura Gonzalez Università della Svizzera Italiana

Analysis of costs and quality of care in orthopedic surgery with continuous regional analgesia: Comparison of outpatient vs. inpatient setting

Hospital Quality

Li-Chen Huang Department of Health

 

The Introduce of Taiwan National Health Insurance Disputes Review System

Assessing Reform

Lilian Peters
University of Groningen, University Medical Center Groningen

Formal health care costs predicted by frailty in a heterogeneous elderly population

Issues in Aging Populations

Luis Salvador-Carulla
University of Sydney

Financing of Illness: Applicability of a new type of health economic research to the analysis of mental health care in nine European countries (REFINEMENT Project)

Mental Health Issues

Martin Hensher Department of Health & Human Services, Tasmania

Long-run economic growth and health systems: alternative scenarios for the future of economic growth and their likely consequences for health and health care

Government Financing for Health Care

María Errea Universidad Pública de Navarra

Evaluation of the Impact of Blood Donations’ Campaigns and Promotion Events in a Spanish Population: A Natural Experiment

Public Health Issues

Svenja Schauer Hannover Medical School

Using claims data to evaluate integrated care contracts: An analysis of potentials and restrictions

Economic Evaluation Methods

Young Eun Kim
Swiss Tropical and Public Health Institute

Costs of scaling up onchocerciasis (river blindness) treatment toward elimination and eradication

Disease Management

David Smith
Center for Health Research, Kaiser Permanente Northwest

Extrapolating Economic Findings from Pragmatic Trials in Integrated Health Systems to the Longer Term using Propensity Scoring and Decision Modeling: An example using adherence to antidepressant medication

Enhancing Cost-Effectiveness Analysis

Ed Wilson
University of East Anglia

A comparison of relative value of information from different resource use data collection processes in an economic evaluation alongside a clinical trial

Enhancing Cost-Effectiveness Analysis

Jan Haeussler University of Konstanz

Diabetes prevention in a specific target group: Evaluation of the M.O.B.I.L.I.S. Program

Prevention Behaviour

Jeremy Barofsky University of Southern California

The economic effects of anti-retroviral therapy in Malawi

Economics and HIV

Joanne Flavel
Flinders University

Poor health and labour market disadvantage: the effects of health on form of employment

Effect of Health Status on Employment

Joseph Lipscomb Emory University

Social Choice Foundations of Cost-Effectiveness Analysis in Health and Medicine: Defining and Satisfying the Corresponding Arrow Conditions for Rational Collective Choice

Health Economic Theory

Raja Jahangeer Pakistan Institute of Development Economics (PIDE)

Health Inequalities in Pakistan: The Role of Gender, Occupation, Household Economic Status and Place of Residence

What Affects Health I

Silvia Mendolia University of Wollongong

The Effect of Non-Cognitive Skills on Health Behaviours in Adolescence

What Affects Health I

Stefan Felder University of Basel

The dead-anyway effect from a societal perspective: Evidence from discrete choice data

Health Economic Theory

 

    

Session: Demand and Supply Considerations for Human Papillomavirus Vaccine (HPV) Introduction in Low and Middle-Income Countries

Session: Demand and Supply Considerations for Human Papillomavirus Vaccine (HPV) Introduction in Low and Middle-Income Countries


Session Title:
Demand and Supply Considerations for Human Papillomavirus Vaccine (HPV) Introduction in Low and Middle-Income Countries

Time: Monday 10:15 a.m.-11:30 a.m.
Room Bayside 104
Session Type: Abstract Driven Session

Chair: Marc Brisson (University of Laval, Centre de recherche FRSQ du CHA universitaire de Québec, Hôpital du Saint-Sacrement)


Organizer (1): Raymond Hutubessy (World Health Organization)

Session Description (476 words)

Human papillomavirus vaccines have several public goods properties that trigger public interventions directed to stimulate both supply and demand. At the macro level there are interventions to support vaccine development, pricing and vaccine procurement in low and middle-income countries (LMICs). At the micro level, there is public sector financing for HPV vaccine service delivery. Despite these interventions, some middle income-countries continue to perceive the vaccine as unaffordable. Is HPV vaccination affordable and how can the likelihood of its introduction be improved?

Purpose:
The purpose of the session is two-fold:
a) To address global and national economic factors influencing HPV introduction decisions, specifically focusing on similarities and differences between developed and developing countries;
b) To introduce and familiarize analysts in low and middle income countries with issues around affordability and value for money of HPV vaccination, together with available economic decision tools to support such decisions.

Content:
Currently decision makers face challenges regarding value for money and affordability issues on HPV vaccine introduction globally. Numerous economic analyses have been conducted to inform vaccine introduction decisions in high income countries. However these economic challenges are different in high income countries compared to low income countries. In the first group of countries the public market price, which can be as high as 130 US$ per dose, offered by vaccine manufacturers is a major obstacle for national decision makers to publicly finance the vaccine. In the low income countries where HPV vaccines prices are negotiated downwards towards relatively low prices (6US$-80US$ per dose) with support from organizations such as the GAVI Alliance or the PAHO revolving fund, the delivery costs of the vaccination program itself have becomes a major introduction barrier rather than the price of the vaccines itself. As the existing infrastructure in many low and middle income countries is not adequate to reach adolescent girls, in particular those not attending schools, substantial investments are required to start up the program in these countries. However, many low and middle income countries report lacking the technical capacity to conduct analyses about the investments they require and their value for money.

The session will start with a discussion on economic considerations that affect comprehensive cervical cancer prevention and control in low- and middle-income countries. The second session will discuss factors influencing the market dynamics of HPV vaccines that affect their affordability including an overview of the tier pricing developments of HPV vaccines globally. Next issues around costing and planning HPV vaccination delivery programs will be discussed, along with a presentation of the WHO’s comprehensive Cervical Cancer Prevention and Control Costing (C4P) tool. The last session will shed on light on the value for money of HPV vaccines in low and middle income countries along with a discussion of using the WHO supported Papillomavirus Rapid Interface for Modelling and Economics (PRIME). Case studies and country experiences will be presented in each session.

Theme: Health technology assessment
Key Terms: Economic evaluations, HPV vaccines, cervical cancer, low and middle income countries

Presentations (3)

  1. Introduction to economic considerations and decision tools for comprehensive cervical cancer prevention and control in LMICs

    Presenter: Ann Levin (Levin and Morgan)
    Theme: Application
    Abstract (150 words)

    This paper reviews the economic considerations that affect comprehensive cervical cancer prevention and control in low- and middle-income countries. It also discusses decision tools that could be used. The authors conducted a review of key factors affecting the introduction in HPV vaccination in low and middle-income countries: burden of disease, HPV vaccine pricing, service delivery costs, and comparison of HPV vaccine with other new and under-utilized vaccines, and source of financing. Several decision tools are available for assisting with the introduction of HPV vaccine. These range from cost analysis, budget impact, epidemiological modeling, cost-effectiveness, and threshold price analysis. The decision to use any of these will depend on which question is being asked by the government. Some tools that have been developed to assist governments with decision-making on the introduction of HPV vaccine – the WHO cervical cancer prevention and control costing tool (C4P costing tool) and PRIME Cost-Effectiveness tool.

    Key Terms: HPV vaccines, cervical cancer, cost analysis, cost-effectiveness analysis
    Authors (2): Ann Levin (Independent Consultant. Health Economist) and Raymond Hutubessy (World Health Organization. Initiative for Vaccine Research)

    Funding Sources: NONE

  2. Is the HPV Vaccine Market favorable for introduction in LMICs?

    Presenter: Claudio Politi (World Health Organization. Expanded Programme for Immunization)
    Theme: Application
    Abstract (293 words)

    Many low and middle income countries are considering the introduction of HPV vaccine as national immunization and reproductive health programs develop strategic plans to prevent and control cervical cancer. However, the affordability of the HPV vaccine is often a major obstacle to its introduction despite some significant reductions in its price. The objective of this paper is to discuss factors influencing the market dynamics of HPV vaccines that affect their affordability. This information will assist policymakers in their decision-making on HPV vaccine introduction. Data were collected on product development, their supply, demand for the vaccines, sources of financing and implementation strategies as well as vaccine revenues and prices in the public and private sector for different countries. Both peer-reviewed and gray literature were reviewed, including summaries of regional meetings on cervical cancer control programs. The study results indicate that the supply and demand for HPV vaccines is highly dynamic as new sources of finance are becoming available for low-income and some lower-middle income countries. In the short-term, the price of the vaccines in high-income countries is likely to remain stable, despite price reductions in some countries, due to the duopoly supply situation and the high cost of production of first-generation vaccines. However, the price of vaccines is decreasing in low and middle-income countries as predictable demand and assured funding are growing and production capacity is not fully used. Demand for the HPV vaccine is gradually becoming more widespread as it becomes more widely available in low- and middle-income countries. Important issues of access to the HPV vaccine remain though for low and middle-income countries. In the longer-term, HPV vaccines created with new technologies and better dialogue between donors, developers, producers and countries are likely to be of lower cost, more suitable and affordable.

    Key Terms: HPV vaccines, cervical cancer, vaccine market, vaccine prices
    Authors (3): Claudio Politi (World Health Organization. Expanded Programme for Immunization) , Ann Levin (Independent Consultant. Health Economist) and Miloud Kaddar (World Health Organization. Expanded Programme for Immunization)

    Funding Sources: Funds from the GAVI Alliance Business Plan 2012.

    Publication History: In Review
    Under review with BMC Medicine

  3. Is it cost-effective to vaccinate girls against HPV in LMICs?

    Presenter: Mark Jit (Health Protection Agency. Modelling and Economics Unit)
    Theme: Application
    Abstract (202 words)

    Introduction: While the cost-effectiveness of vaccinating girls against HPV prior to sexual debut has been extensively investigated in high income countries, there have been fewer studies in LMICs. Assessing the cost-effectiveness of HPV vaccination often requires the use of complex models with data and expertise requirements that are prohibitive in such settings. However, some situations can be investigated using much simpler models. Methods: PRIME (Papillomavirus Rapid Interface for Modelling and Economics) is a simple Excel-based model that estimates an upper bound for the cost-effectiveness of vaccinating girls prior to sexual debut against HPV in a setting with no routine screening. PRIME was validated against published HPV cost-effectiveness studies in the literature and used with publicly available data sources to evaluate HPV cost-effectiveness in all 141 LMICs. Results: Female HPV vaccination is likely to be cost-effective in most countries at prices similar to those at which the GAVI Alliance purchases the vaccines under its Advanced Market Commitments. As prices increase above this however cost-effectiveness is less certain. Discussion: Models like PRIME offer a way of rapidly assessing the cost-effectiveness of HPV vaccination in simple situations, and are complementary to more complex models that can evaluate other situations such as catch-up and male vaccination.

    Key Terms: HPV vaccines, cervical cancer, cost analysis, cost-effectiveness analysis
    Authors (4): Mark Jit (Health Protection Agency. Modelling and Economics Unit) , Allison Portnoy (World Health Organization. Initiative for Vaccine Research) , Marc Brisson (University of Laval. Research Unit, Population Health) and Raymond Hutubessy (World Health Organization. Initiative for Vaccine Research)

    Funding Sources: This work was funded by the World Health Organization.

Session: Dealing With HIV

  Session:Dealing With HIV

Session Title: Dealing With HIV

Time: Monday 5:15 p.m.-6:30 p.m.
Room Bayside Terrace
Session Type: Abstract Driven Session

Chair: Anna Vassall (London School of Hygiene and Tropical Medicine)


Presentations (4) 

  1. The Value of Reducing HIV Stigma

    Presenter: Robert Brent (Fordham University. Economics)
    Theme: Methodology
    Abstract (492 words)

    Abstract: Rationale: Globally, by the end of 2011 there were 34.0 million people living with HIV/AIDS. With 2.5 million new cases of HIV and 1.7 million AIDS deaths, the HIV epidemic is still on the rise. UN Secretary General, Ban Ki-Moon (2008) states that stigma is a chief reason why the AIDS epidemic continues to devastate societies worldwide. He argues that because of stigma people do not get tested and, if tested, do not seek treatment. So HIV transmission increases greatly because of the existence of stigma. If one could obtain estimates of how beneficial it would be in monetary terms to reduce HIV stigma then one could decide how much resources should be devoted to interventions that would lead to the reduction of HIV stigma. Objectives: The main objective of this paper is to show how the value of reductions in HIV stigma could be obtained by estimating the utility function and finding the marginal rate of substitution (MRS) between stigma and income. Although we will be focusing on HIV stigma reduction, it is important to recognize that stigma is a widespread phenomenon that affects access to services in many branches of the health care field. Our methods could be adapted to apply to valuing any type of stigma reduction. Methodology: We used happiness as our utility measure and happiness is increasingly being used to evaluate outcomes of economic policies, see Graham (2009). We used a recursive estimation framework whereby stigma first determined income and then the income-influenced stigma determined utility. Three different expressions for the MRS are derived and each of these leads to an alternative estimation method. To illustrate how our framework can be used we applied it to a sample of elderly people living in NYC with HIV. Data: Data for the study are related to the 2006 survey by the AIDS Community Research Initiative of America (ACRIA). This is a self-reported data set of 914 individuals with HIV in New York City. We used from this data set information on happiness (life satisfaction on a scale with 1 as the minimum and 10 as the maximum), income adequacy (ranging from $22,281 to $68,026) and HIV stigma (using the Berger scale ranging from 40 to 160). Conclusions: The total value of stigma reduction is rather large at around $1,000 per unit. The challenge to evaluators of HIV policies is to come up with interventions that impact stigma. It is unlikely that HIV stigma can be completely reduced, which for our measure was 120 points. However, interventions should be able to be identified that reduce stigma by a few points, say five. Our study can be used to value the benefits, which would be $5,000. Estimating the costs of the intervention then would allow an Economic Evaluation to be undertaken. Whether one uses an educational program, a job training scheme or anti-discriminatory regulation, one now has an estimate of how much resources should be devoted to implementing these interventions.

    Biographical Details:

    Currently (since 1995), Professor of Economics at Fordham University, Bronx, NY 10458.
    Specializes in Cost-Benefit Analysis for policies in Developed and Developing Countries. Recent research related to evaluating interventions for HIV/AIDS.

    Key Terms: HIV Stigma, Marginal Rate of Substitution (MRS), Older Adults
    Author (1): Robert J. Brent (Fordham University. Economics)

  2. An economic assessment of decentralizing anti-retroviral services from hospitals to primary health care centers in Nigeria: A matched difference-in-difference analysis

    Presenter: Elaine Baruwa (Abt Associates, Inc.. International Health Division)
    Theme: Application
    Abstract (492 words)

    Nigeria launched a ‘hub and spoke’ decentralization pilot in March 2010 for the provision of anti-retroviral therapy (ART). In this program, stable ART patients at hospitals (hubs) were downward referred to primary health care centers (spokes) for the continued provision of ART. The rationale for decentralization was to relieve congestion at the hospital level and to provide better access to care for patients not living near the hospital. The program may also save resources by moving care from more expensive hospitals to less expensive health centers. USAID’s Health Systems 20/20 project performed a costing study of ‘hub and spoke’ services. The objectives of this study are to compare the cost of ART care provided through the two levels of care, and understand the implications of cost differences for scale up of the ‘hub and spoke’ model. The study adopts a government perspective, with an analytic horizon including one year pre- and one year post-decentralization. Data were collected from facilities and patient records from Kaduna and Cross Rivers States. In Cross Rivers, data were extracted for 198 decentralized patients from four spoke sites and 200 non-decentralized patients from the hub site. These numbers were 285 and 243 respectively for the five spoke and one hub sites in Kaduna. Non-decentralized patients were matched to decentralized patients by date of ART initiation. Comparisons between patients before and after decentralization were made to assess changes in the receipt of care; difference-in-difference assessment was done between the two groups to assess differences in the receipt of care and the cost of care due to decentralization. Selected decentralized and non-decentralized patients had similar profiles in terms of age, CD4 counts, and sex when they initiated ART and again at the time when decentralized patients were referred to spoke sites, indicating a reasonable match between the comparison groups. Both groups had more visits and fewer missed visits in the year after decentralization, suggesting that decentralization may have improved access for both sets of patients. Decentralized patients had a greater decline in the number laboratory tests post-decentralization than their counterparts (p<0.05). However, fewer than the recommended number of laboratory tests was being conducted across all patients even before decentralization. Decentralized patients’ average cost of ART care was $355 per person per year in the year before decentralization and $388 after decentralization (p=0.51). For patients staying at the hospitals, these costs were $316 per person per year before decentralization and $447 after (p<0.01). In the difference-in-difference analysis, the increase in cost for non-decentralized patients was greater than that for decentralized patients (p<0.05). Decentralization of ART services appears to increase access to general ART care, but may limit access to ART laboratory services for decentralized patients. Decentralization is also likely to result in greater efficiency in the delivery of services, especially as health centers take on a greater number of patients. This study is limited by not including costs incurred above the facility level, such as training, or costs borne by patients.

    Biographical Details:

    Dr Elaine Baruwa is a Senior Associate and Health Economist at Abt Associates. Elaine was conducted economic evaluations of MCH and HIV programs across Africa and currently manages USAID's Health Financing and Governance Project in Haiti that focuses on health financing and human resources management. She has an MSc. in Health Management from Imperial College University and a PhD in International Health from the Johns Hopkins Bloomberg School of Public Health.

    Key Terms: HIV, Decentralization, Efficiency, Costing
    Authors (2): Elaine Baruwa (Abt Associates, Inc.. International Health Division) and Ben Johns (Abt Associates, Inc.. International Health Division)

    Funding Sources: USAID's Health Systems 20/20 Project

  3. Examining the links between staff flexibility, workload, and service delivery in the context of SRH and HIV service integration: a case study of selected government facilities in Kenya

    Presenter: Sedona Sweeney (London School of Hygiene & Tropical Medicine. Department of Global Health and Development)
    Theme: Application
    Abstract (429 words)

    Background: There is a great deal of interest in integrating HIV and sexual reproductive health (SRH) services in low-income countries. It is often assumed that integration can improve service access and quality while reducing the cost of service delivery. Economic theory also indicates that integration could provide a greater flexibility of use of human resources, potentially improving the efficiency of health services. On the other hand, integration often requires reorganization of existing service delivery models and health workers may be concerned about increases in workload. We therefore examine the variation in staff orientation to different tasks and workload in integrated HIV/SRH care, and explore how this may be linked to unit costs. Methods: As part of the Integra Initiative in Kenya, cost and output data were collected in 11 government health facilities supported by a project aiming to enable the integration of HIV and SRH services through training, management support and the provision of resources. Baseline data was collected for the financial year 2008-09, and endline data was collected for 2010-11. Unit costs per visit and per episode of care were estimated for family planning (FP) and provider-initiated HIV counselling and testing (PITC) services. Staff time was allocated as a percentage of clinical staff full-time equivalency (FTE) according to service mix and time use. We assessed the level of task orientation based on the number of different types of health services routinely provided by one clinical staff member. Results: From baseline to endline, flexibility in the range of services provided increased among clinical staff across facilities integrating FP and PITC (increasing from 3.8 services to 5.2 services per staff member). The effect on staff time, however, varied. District hospitals and sub-district hospitals saw minimal change in the amount of total staff time spent on FP and PITC, however health centres saw a large increase in total staff time (total FTE increased by 90%). These health centres did not see an increase in workload on individual staff members resulting from the integration, as additional staff were hired in as Kenya expanded its health workforce. The total number of PITC services delivered increased by 17%, however the number of FP services fell by 6% keeping the overall number of services delivered relatively constant. Further work is currently underway to examine the relationship between multi-tasking, service delivery and unit cost. Conclusion: Our initial results suggest that while support to enable integration can increase the multi-tasking of staff, this does not necessarily reduce the amount of time spent providing services. Further work is on-going to examine the impact of multi-tasking on service efficiency.

    Key Terms: integration, human resources, HIV

    Authors (6): Sedona Sweeney (London School of Hygiene and Tropical Medicine. Department of Global Health and Development) , Carol Dayo Obure (London School of Hygiene and Tropical Medicine. Department of Global Health and Development) , Anna Vassall (London School of Hygiene and Tropical Medicine. Department of Global Health and Development) , Christine Michaels-Igebokwe (London School of Hygiene and Tropical Medicine. Department of Global Health and Development) , Fern Terris-Prestholt (London School of Hygiene and Tropical Medicine. Department of Global Health and Development) and The Integra Team ( . )

    Funding Sources: This work was supported by a grant from the Bill and Melinda Gates Foundation.

  4. How effective are cash transfer programmes among Children affected and infected with HIV?: An Evaluation study from South India

    Presenter: Edwin Sam Asirvatham (AIDS Prevention and Control Project. Voluntary Health Services)
    Theme: Application
    Abstract (433 words)

    Background In India, children affected and infected with HIV are primarily from the poor households and they are deprived of basic needs in terms of food, basic health care, shelter and education. The government of Tamil Nadu responded to this situation by developing the first cash transfer program in India for the children infected and affected by HIV to address the children’s education, nutrition, medical and socioeconomic needs. This was operationalized through an Orphan and Vulnerable Children (OVC) Trust with a corpus fund of $1million. Objectives The objective of the study was to assess the effectiveness of this cash transfer program in achieving its intended purposes. Methods The study was undertaken in 10 districts that were selected from four clusters of districts in Tamil Nadu state. Out of the 655 beneficiaries, a sample of 153 beneficiaries was selected using the probability to proportionate size method from each district. Interviews were conducted using a semi-structured interview schedule. The caretakers were interviewed for children below 15 years. Biometric markers (hemoglobin and CD4) of children on ART were collected from medical records. The latest available data before the cash transfer programme and latest available data during the interviews were taken for comparison. Results Among study participants, 73% of them were HIV infected and the remaining were affected children; around 37% were double orphans, 53% were paternal orphans and 10% were maternal orphans; majority were (63.4%) from rural areas and the average age was 11.46 years. 30% of the children were under the care of their grandparents. The average age of the care givers was 44 years (Range: 20 to 85 years). Food expenditure was considered as the primary household expenditure for 89% of the respondents. The household income is positively correlated with food consumption (r=.607; p<.001) indicating less scope for other basic needs. The cash transfer programmes disbursed an average amount of INR 2617(USD 52). Most interviewees reported improvement in school attendance (98%) and performance (94%) that included high marks and participation in extracurricular activities. Around 42% reported an improvement in the food consumption pattern. Among children on ART (81), both mean hemoglobin level (10.04 mg to 10.76 mg; p<.001) and mean CD4 level (738.75 to 1014.34; p<0.01) increased significantly. Conclusion The findings provide evidence related to the effectiveness of cash transfer program among children especially in supporting their education. This program has contributed in restoring their childhood and this model can be replicated in other similar situation/area. However, the program was able to reach only a low proportion of eligible beneficiaries. It is imperative to scale up the program by adopting appropriate resource mobilization initiatives.

    Key Terms: Cash Transfer Programmes, Effectiveness, Children Infected with HIV
    Authors (2): Edwin Sam Asirvatham (AIDS Prevention and Control Project. Voluntary Health Services) and Bimal Charles (AIDS Prevention and Control Project. Voluntary Health Services)

    Funding Sources: Nil

 

Communicable diseases, HIV-AIDS, and vaccines

Klasifikasi Keyword Abstrak

Klasifikasi Keyword Abstrak

  Communicable diseases, HIV-AIDS, and vaccines

  Costs of care

  Discrete Choice Experiments

  Economic evaluations and methods

  Equity and equality

  Health care reform

  Health financing

  Health policy

  Health professions

  Health providers and patient choice

  Hopital and hopital management

  Maternal and child health

  Mental health and elederly health issues

  Non-communicable diseases, tobacco, and nutrition

  Patient behavior and behavioral economics

  Pharmaceutical and substances

  Private sector in universal health coverage era

  Quality of care

  Service delivery, access and health care utilization

  Universal Health Coverage

 

Download Slides

Name

Presentation

Session

Download Slide

Chean Men Rithy
Chean & Jaco Research

Social health protection for NCDs in Cambodia

Demand Side Interventions to Boost Access to Affordable Health Services in Low Income Settings: The Cases of Cambodia, the Lao People’s Democratic Republic, and Rwanda

 

ds

Donald Shepard
Brandeis University

Cost-effectiveness of Insecticide Treated Wall Liner for Malaria Prevention in Rural Western Kenya

Malaria and Dengue: Costs and Cost-Effectiveness of Control Strategies Against Two Major Mosquito-Borne illnesses

Jason Abaluck
Yale University

Dynamics of Plan Choice in Medicare Part D

Health Insurance Choice

Lo Veasnakiry
Ministry of Health

Cambodia – Scaling up and consolidation of health equity fund under national health financing policy reform

Beyond Bismark and Beveridge: Innovative Financing Mechanisms for Protecting the Poor in Cambodia, Pakistan and Bangladesh

Ulla Kou Griffiths London School of Hygiene & Tropical Medicine

 

Cost-utility analysis of cataract surgery and refractive error correction in Zambia

Economics of Eye Health: New Methodological Approaches to Measure Costs and Benefits of Eliminating Avoidable Blindness

Yara Halasa
Brandeis University

Dengue in India: Cost of illness

Malaria and Dengue: Costs and Cost-Effectiveness of Control Strategies Against Two Major Mosquito-Borne illnesses

Alex Robson

Griffith University

Price Carrots and Income Tax Sticks in Private Health Insurance Markets: Fiscal Implications and Welfare Consequences

Theoretical Studies of the Impacts of Australian Healthcare Reform Policies on Healthcare Markets

Brendan Mulhern University of Sheffield

Using a Discrete Choice Experiment Incorporating Duration to Value Health States: A Feasibility Study Using EQ-5D-5L

Discrete Choice Experiments: A Review of the Methodological Challenges of Applying DCEs to Value Generic Quality of Life Measures

Marleen Dekker
Leiden University

Understanding participation in community based health insurance: findings from Togo

Health Care Financing Reforms and their Effects in Sub-Saharan Africa: Case Studies from Ethiopia, Togo, Rwanda and Burundi

Sergio Prada Universidad de Icesi

A systematic measurement and new evidence of the costs of providing health care in Colombia

The Production and Costs of Health Service Across Developing Countries

Andrea Leiter-Scheiring
University of Innsbruck

Risky Sports and the Value of Life Saving Information

Public Health Issues

Christopher Hollenbeak
Pennsylvania State University

Efficiency Evaluation of Healthcare in Pennsylvania Prisons

Economic Evaluation of Systems

Edwine Barasa
KEMRI-Wellcome Trust Research Programme

Examining Priority Setting and Resource Allocation Practices in Hospitals: The Case of a District Hospital in Kenya

Hospital Quality

Evelyn Thsehla
Council for Medical Schemes

What are the key contributing factors for hospital admissions, readmission rate and day cases within the South African medical schemes community?

Hospital Quality

Filipinas Bundoc
University of the Philippines

The role of frequency and timing of antenatal care seeking in securing neonatal survival: a Philippine case

Child Health

Gert Westert
Radboud University Nijmegen Medical Centre

The Dutch Atlas of Health Care Variation; transparency needed to increase efficiency.

Assessing Reform

Heather McLeod Ministry of Health

Estimating the Future Need for Palliative Care: a tale of two methodologies

Economic Evaluation Methods

Hyun-Woung Shin Korea Institute for Health and Social Affairs

Determinants of Health Care Spending Growth in a Government-Funded Medical Assistance Program: Evidence from South Korea

Government Financing for Health Care

Ian Anderson
World Bank

Plenty amidst scarcity: The case of Samoa, Tonga and Vanuatu

Government Financing for Health Care

Jackie Mundy
AusAID Health Resource Facility

Evolving health care financing issues in East Asia and the Pacific

Government Financing for Health Care

 

    

Laporan Semiloka

Laporan Semiloka:

Potensi dan Pengelolaan sistem telematika untuk mengembangkan RS
di daerah sulit dan melebarkan akses masyarakat terhadap pelayanan kesehatan.

Yogyakarta, 17 Juli 2013


 

 Pengantar

Pada tanggal 16 Juli 2013 Ibu Menteri Kesehatan membuka unit Pendidikan dan Pelatihan Jarak Jauh berbasis digital di Badan PPSDM. Peresmian ditandai dengan melakukan diskusi teleconference bersama pejabat Dinas Kesehatan di 4 propinsi. Empat tahun yang lalu Pusat Kebijakan dan Manajemen Kesehatan FK UGM memulai Program Pengembangan Ilmu berbasis Web. Teknologi Web untuk menyimpan, menyiarkan secara hidup dalam bentuk audio visual semakin maju. Gadget semakin banyak dipegang oleh masyarakat. 3 tahun yang lalu, Infrastruktur IT di berbagai tempat terpencil sangat sulit. Sekarang sudah ada teknologi VSAT dipasang di seluruh Dinas Kesehatan dan RSD. Sudah ada "jalan raya besar" untuk dipergunakan. PKMK FK UGM sudah menggunakan untuk NTT dan Papua. Peresmian unit Pendidikan danPelatihan Jarak Jauh di Kemenkes menandai era baru dalam telematika.

 

 Kegiatan Semiloka hari ini adalah:

Membahas Potensi dan Pengelolaan sistem telematika untuk mengembangkan RS di daerah sulit dan melebarkan akses masyarakat terhadap pelayanan kesehatan.

 

 Tujuan Pertemuan:

  1. Membahas pengalaman PKMK menggunakan teknologi telekomunikasi di Papua dan NTT ;
  2. Memahami teknologi VSAT dan sistem jaringan Pusdatin dan Telkom untuk pengembangan.
  3. Membahas sistem tele-training dan telemedicine yang membutuhkan struktur, dana, tenaga ahli, dan kegiatan yang terkoordinasi;
  4. Mengembangkan telehealth dan telemedicine lebih lanjut untuk RS di daerah sulit
  5. Membahas Proses Bisnis Sistem Pengembangan Ilmu berbasis Telematika

 

  Hasil pertemuan

Pertemuan telah membahas pengalaman PKMK UGM menggunakan teknologi telekomunikasi di Papua dan NTT dalam pelatihan bagi Kepala Dinas Kesehatan, Kepala Puskesmas, dan staf yang dilakukan secara kombinasi dengan tatap muka. Disamping itu bekerjasama dengan RS Harapan Kita telah mencoba menggunakan telemedicine dalam berbagai kasus Obsgin di RSD Kefa. Masalah yang masih timbul adalah gangguan teknis komunikasi. Gangguan ini diantisipasi dengan menggunakan back-up berupa sambungan telepon. Adanya jaringan VSAT dari Kementerian Kesehatan bekerjasama dengan PT Telkom memberi dorongan baru untuk pengembangan dengan catatan diharapkan menaikkan kapasitas menjadi 512Kb. Saat ini baru 126 yang lebih dari cukup untuk manajemen dan pengiriman data, namun sangat kurang untuk keperluan video. Dalam pertemuan dibahas pula sistem agar kegiatan ini dapat berjalan jangka lama.

 

Tindak lanjut pertemuan:

  1. Pengembangan sistem telematika untuk NTT dan Papua terus dilakukan bersama dengan Kemenkes, Pusdatin. Khusus untuk telemedicine diharapkan ada pertemuan untuk aspek hukumnya.
  2. Perlu dilakukan pengembangan untuk isi yang dapat dimanfaatkan oleh tenaga rumahsakit, Dinas Kesehatan, dan puskesmas yang akan tersambung dengan infrastruktur SIKNAS Pusdatin.
  3. UGM dan perguruan tinggi lain diharapkan menjadi semacam production house untuk kegiatan. Sebagai kegiatan awal akan dilakukan beberapa hal:
    1. Penyusunan Program Pembelajaran untuk: Hand-washing, Manual Rujukan, dan Pemetaan Intervensi KIA dengan dana UGM dan AIPMNH
    2. Penyusunan Program Pembelajaran mengenai Kepemimpinan RS dan Kepemimpinan Dinas Kesehatan, bekerja sama dengan UGM
    3. Pengembangan program pembelajaran untuk peningkatan mutu pelayanan Rumahsakit.
    4. Pengembangan program pembelajaran untuk Pemasangan IUD pasca persalinan.
    5. Pengembangan program pembelajaran untuk Penguatan IT di Kabupaten, bekerjasama dengan SIMKES.
    6. Kegiatan akan dimulai pada minggu ke empat bulan Juli 2013.
    7. Disamping itu diharapkan ada Penelitian Operasional dengan tema: Penggunaan Sarana SIKNAS Pusdatin untuk pembelajaran penggunaan prinsip Health System Strengthening untuk pengendalian AIDS, TB, dan Malaria. Kerjasama diharapkan antara UGM dengan Pusdatin dengan dana Global Fund.
    8. Diharapkan produk-produk ini akan ditempatkan di website PKMK http://chpm.fk.ugm.ac.id/ dan dapat diakses oleh seluruh RS dan Dinas Kesehatan di Indonesia melalui jaringan SIKNAS Pusdatin.
       
  4. Direncanakan ada pertemuan nasional untuk membahas penggunaan jaringan VSAT Kemenkes Pusdatin dengan berbagai kemungkinan dan contoh isinya.

Diskusi Bulanan PKMK - Juli Tahun 2013

Diskusi Bulanan Tahun 2013
Pembahasan Artikel Kebijakan dan Manajemen

Kelompok Kerja Kebijakan dan Manajemen Fakultas Kedokteran UGM

Ruang Kuliah R.E. 301, Lt. 3 Gedung IKM Sayap Utara, FK UGM
Jumat, 23 Juli 2013

 

 Pengantar

Perkembangan topik dan metode penelitian manajemen berjalan dengan sangat pesat. Perkembangan ini perlu diikuti dengan cara melakukan pembahasan terhadap artikel-artikel kebijakan dan manajemen. Kegiatan ini sangat penting untuk pengembangan kapasitas para dosen, peneliti, dan konsultan yang tergabung pada kelompok kerja Kebijakan dan Manajemen Pelayanan Kesehatan FK UGM serta peminat lain. Kegiatan ini dipancarkan melalui video dan audio streaming sehingga para peserta yang berada di luar Yogyakarta dapat mengikutinya.

 

  Tujuan

  1. Membahas perkembangan topik yang menarik dalam kebijakan dan manajemen kesehatan
  2. Membahas metode penelitian, pelatihan, dan konsultasi, yang dipergunakan di berbagai penelitian kebijakan dan manajemen
  3. Menjadi forum untuk pengembangan kemampuan diri untuk para konsultan, peneliti, dan dosen di kelompok kerja kebijakan dan manajemen kesehatan
  4. Mengembangkan forum komunikasi antara dosen, peneliti, dan konsultan dalam kebijakan dan manajemen pelayanan kesehatan.

 

  Jadwal Acara dan Topik

Topik

Konsep-konsep Terkait

Makalah yang ditelaah

Principal-agent theory & Self-determination theory

Conflict of interest, Motivation, Classical agency theory

diskusi-bulanan-juli

Gopalan, S.S., & Durairaj, V. (2012).

Addressing maternal healthcare through demand side financial incentives: experience of Janani Suraksha Yojana program in India. BMC Health Services Research12:319 (15 September 2012). PDF

Carroll, J.K., dkk. (2012).

A 5A's communication intervention to promote physical activity in underserved populations. BMC Health Services Research12:374 (30 October 2012). PDF

 

  Arsip Video Presentasi

Sesi 1

Sesi 2

  • angka jitu
  • togel 4d
  • agen togel
  • slot 4d
  • bandar toto 4d
  • togel 4d
  • togel online
  • rajabandot
  • slot gacor
  • toto macau
  • toto macau
  • toto macau
  • toto macau
  • situs toto
  • situs slot
  • rtp live slot
  • toto slot
  • bandar slot
  • toto macau
  • bandar togel online
  • togel online
  • togel sdy
  • togel online
  • toto macau
  • hongkong lotto
  • hongkong lotto
  • situs slot
  • slot gacor
  • bandar slot 4d
  • bandar slot
  • bandar slot gacor
  • bandar slot gacor
  • slot dana
  • toto macau
  • bandar togel 4d
  • wengtoto
  • toto hk
  • slot dana
  • hk lotto
  • toto sdy
  • slot gacor
  • slot 5000
  • toto slot
  • toto togel 4D
  • toto macau
  • slot thailand
  • slot gacor
  • togel sidney
  • live draw sgp
  • Bandar Slot
  • bandar slot gacor
  • togel macau
  • toto slot
  • slot qris
  • slot toto 4d
  • Toto Togel 4D
  • sdy lotto
  • bola gacor
  • slot 5000
  • toto hongkong
  • toto slot
  • slot 5000
  • slot 5000
  • toto togel
  • slot 5000
  • slot 5000
  • slot 5000
  • situs toto
  • BATASRAJABANDOT
  • slot 777
  • slot gacor
  • slot gacor
  • Bandar Slot
  • Situs Slot
  • Bandar Slot
  • Slot Gacor
  • situs slot
  • slot toto Gacor
  • Bandar Situs Slot Gacor
  • slot online
  • bokep
  • toto slot
  • Slot Demo
  • situs togel
  • bola slot
  • hitam slot
  • permainan slot
  • dewa slot
  • agent slot
  • slot toto
  • slot gacor
  • slot gacor
  • toto slot
  • akun demo slot
  • toto slot
  • slot gacor
  • slot gacor
  • https://heylink.me/iblbettotoslot